SCHEMBL1746471

SCHEMBL1746471

CCC(CC(=O)O)c1ccc(OC/C=C(\c2ccc(Cl)cc2)c2ccc(C#CCN3CCOCC3)cc2)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 4/20 0.43
TDP1 Q9NUW8 1/20 0.43
PPARD Q03181 4/20 0.41
LMNA P02545 2/20 0.37
MAPK1 P28482 1/20 0.37
MMP13 P45452 2/20 0.36
FKBP1A P62942 1/20 0.36
PPARG P37231 2/20 0.36
PPARA Q07869 2/20 0.36
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TP53 P04637 1/20 0.34
JAK2 O60674 1/20 0.34
PAX8 Q06710 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1745146 0.89 KDM4E (0.47) KDM4EALDH1A1TDP1PPARDLMNA
SCHEMBL29801093 0.89 KDM4E (0.47) KDM4EALDH1A1TDP1PPARDLMNA
SCHEMBL1746379 0.89 KDM4E (0.47) KDM4EALDH1A1TDP1PPARDLMNA
SCHEMBL1745140 0.89 KDM4E (0.47) KDM4EALDH1A1TDP1PPARDLMNA
SCHEMBL1744830 0.85 PPARD (0.55) KDM4EALDH1A1TDP1PPARDPPARG
SCHEMBL1744826 0.85 PPARD (0.55) KDM4EALDH1A1TDP1PPARDPPARG
SCHEMBL1744825 0.85 PPARD (0.55) KDM4EALDH1A1TDP1PPARDPPARG
SCHEMBL1747437 0.85 KDM4E (0.44) KDM4EALDH1A1TDP1PPARDLMNA
SCHEMBL1746469 0.85 KDM4E (0.44) KDM4EALDH1A1TDP1PPARDLMNA
SCHEMBL16552762 0.84 PPARD (0.54) KDM4EALDH1A1TDP1PPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2386540-A1 Novel compounds, their preparation and use High Point Pharmaceuticals, LLC (US) 2011-11-16 EP disclosed
US-20110245244-A1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS HIGH POINT PHARMACEUTICALS, LLC (US) 2011-10-06 US disclosed
US-7943613-B2 Compounds, their preparation and use HIGH POINT PHARMACEUTICALS, LLC (US) 2011-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245244-A1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS PPARG, PPARA, PPARD KDM4E 2717/4885ALDH1A1 198/4885TDP1 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.